Breaking News

Vetter Breaks Ground on Des Plaines Manufacturing Site

The clinical site is expected to be completed and ready for media fill by the end of 2029.

Author Image

By: Charlie Sternberg

Associate Editor

Vetter, a global Contract Development and Manufacturing Organization (CDMO), has begun construction of its new clinical manufacturing site in Des Plaines. With an investment of approximately $285 million, this new facility underscores Vetter’s dedication to delivering high-quality services and drug products during early clinical development. Upstream and ground preparation work on the premises started back in April. Vetter’s construction plans include a 160,000 square foot clinical production...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters